Juan Turnés

4.9k total citations
61 papers, 1.7k citations indexed

About

Juan Turnés is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Juan Turnés has authored 61 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Hepatology, 36 papers in Epidemiology and 14 papers in Surgery. Recurrent topics in Juan Turnés's work include Liver Disease Diagnosis and Treatment (33 papers), Liver Disease and Transplantation (27 papers) and Hepatitis C virus research (26 papers). Juan Turnés is often cited by papers focused on Liver Disease Diagnosis and Treatment (33 papers), Liver Disease and Transplantation (27 papers) and Hepatitis C virus research (26 papers). Juan Turnés collaborates with scholars based in Spain, United Kingdom and United States. Juan Turnés's co-authors include Juan Carlos García‐Pagán, Juan G. Abraldeṣ, Jaime Bosch, Manuel Hernández‐Guerra, Rafael Bañares, Agustı́n Albillos, Jackie Bosch, Rosario González, Annalisa Berzigotti and Alessandra Dell’Era and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Juan Turnés

55 papers receiving 1.6k citations

Peers

Juan Turnés
Rubén Terg Argentina
Michael D. Leise United States
B.A. Payer Austria
Juan Turnés
Citations per year, relative to Juan Turnés Juan Turnés (= 1×) peers Alberto Zanetto

Countries citing papers authored by Juan Turnés

Since Specialization
Citations

This map shows the geographic impact of Juan Turnés's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Juan Turnés with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Juan Turnés more than expected).

Fields of papers citing papers by Juan Turnés

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Juan Turnés. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Juan Turnés. The network helps show where Juan Turnés may publish in the future.

Co-authorship network of co-authors of Juan Turnés

This figure shows the co-authorship network connecting the top 25 collaborators of Juan Turnés. A scholar is included among the top collaborators of Juan Turnés based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Juan Turnés. Juan Turnés is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Darnell, Anna, Marc Comas‐Cufí, B. Pérez-Saborido, et al.. (2024). Utilizing a domain-specific large language model for LI-RADS v2018 categorization of free-text MRI reports: a feasibility study. Insights into Imaging. 15(1). 280–280. 11 indexed citations
2.
Aller, R., José Luís Calleja, Javier Crespo, et al.. (2023). Fibrosis avanzada asociada a esteatohepatitis no alcohólica (NASH) en España: resultados de un estudio Delphi. Gastroenterología y Hepatología. 47(4). 337–346.
4.
Lazarus, Jeffrey V., Camila A Picchio, Soo Aleman, et al.. (2021). Hepatitis C standards of care: A review of good practices since the advent of direct-acting antiviral therapy. Clinics and Research in Hepatology and Gastroenterology. 45(2). 101564–101564. 13 indexed citations
5.
Picchio, Camila A, Sabela Lens, Manuel Hernández‐Guerra, et al.. (2021). Late presentation of chronic HBV and HCV patients seeking first time specialist care in Spain: a 2-year registry review. Scientific Reports. 11(1). 24133–24133. 15 indexed citations
6.
Turnés, Juan, Diego Rincón, José Luís Calleja, et al.. (2021). Non-pharmacologic direct cost of a simplified strategy with glecaprevir/pibrentasvir for 8 weeks in naïve non-cirrhotic patients with hepatitis C implemented in clinical practice. The Just SIMPLE Study. Gastroenterología y Hepatología. 45(5). 342–349. 1 indexed citations
7.
Bollipo, Steven, Devika Kapuria, Atoosa Rabiee, et al.. (2020). One world, one pandemic, many guidelines: management of liver diseases during COVID-19. Gut. 69(8). 1369–1372. 31 indexed citations
8.
Turnés, Juan, Raquel Domínguez‐Hernández, & Miguel Casado. (2017). Value and innovation of direct-acting antivirals: long-term health outcomes of the strategic plan for the management of hepatitis C in Spain. Revista Española de Enfermedades Digestivas. 109(12). 809–817. 16 indexed citations
9.
Turnés, Juan, Raquel Domínguez‐Hernández, & Miguel Casado. (2017). Análisis coste-efectividad de dos estrategias de tratamiento para la hepatitis C crónica: antes y después del acceso a los agentes antivirales de acción directa en España. Gastroenterología y Hepatología. 40(7). 433–446. 16 indexed citations
10.
Buti, Marı́a, Itziar Oyagüez, Raúl J. Andrade, et al.. (2014). [Cost-utility analysis of triple therapy with telaprevir in treatment-naïve hepatitis C patients].. SHILAP Revista de lepidopterología. 38(5). 418–29. 9 indexed citations
11.
Albillos, Agustı́n, José Luís Calleja, Esther Molina, et al.. (2014). Terapia triple en pacientes con fibrosis avanzada y cirróticos: aspectos relevantes en la práctica clínica. Gastroenterología y Hepatología. 37. 13–22.
12.
Romero‐Gómez, Manuel, Ramón Planas, Javier Ampuero, et al.. (2013). Meta‐analysis: pegylated interferon α‐2a achieves higher early virological responses than α‐2b in chronic hepatitis C. Alimentary Pharmacology & Therapeutics. 37(11). 1065–1073. 6 indexed citations
13.
Varela, Marı́a, María Reig, Manuel de la Mata, et al.. (2009). Tratamiento del carcinoma hepatocelular en España. Análisis de 705 casos en 62 centros. Medicina Clínica. 134(13). 569–576. 39 indexed citations
14.
Abraldeṣ, Juan G., Agustı́n Albillos, Rafael Bañares, et al.. (2009). Simvastatin Lowers Portal Pressure in Patients With Cirrhosis and Portal Hypertension: A Randomized Controlled Trial. Gastroenterology. 136(5). 1651–1658. 321 indexed citations
15.
Turnés, Juan, Juan Carlos García‐Pagán, Carles Aracil, et al.. (2008). Portal Hypertension–Related Complications After Acute Portal Vein Thrombosis: Impact of Early Anticoagulation. Clinical Gastroenterology and Hepatology. 6(12). 1412–1417. 131 indexed citations
16.
Hernández‐Guerra, Manuel, Juan Carlos García‐Pagán, Juan Turnés, et al.. (2006). Ascorbic acid improves the intrahepatic endothelial dysfunction of patients with cirrhosis and portal hypertension. Hepatology. 43(3). 485–491. 93 indexed citations
17.
Turnés, Juan, Manuel Hernández‐Guerra, Juan G. Abraldeṣ, et al.. (2005). Influence of beta‐2 adrenergic receptor gene polymorphism on the hemodynamic response to propranolol in patients with cirrhosis†. Hepatology. 43(1). 34–41. 28 indexed citations
18.
Hernández‐Guerra, Manuel, Pablo Bellot, Carlos Piera, et al.. (2005). Systemic hemodynamics, vasoactive systems, and plasma volume in patients with severe Budd‐Chiari syndrome†. Hepatology. 43(1). 27–33. 29 indexed citations
19.
Hernández‐Guerra, Manuel, Juan Turnés, Pablo Rubinstein, et al.. (2004). PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome. Hepatology. 40(5). 1197–1202. 103 indexed citations
20.
Turnés, Juan, et al.. (2001). Stenosis of the suprahepatic inferior vena cava as a complication of transjugular intrahepatic portosystemic shunt in Budd-Chiari patients. Liver Transplantation. 7(7). 649–651. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026